We understand the unique challenges faced by emerging pharmaceutical and biotech companies, including funding constraints, intense time pressures, and limited experience and resources beyond the discovery phase. Approximately 75% of our clients are emerging pharma and biopharma organizations. Every day we help remove the barriers that stand between their discoveries and the patients who need them. We provide instant access to comprehensive capabilities for the development and manufacturing of both large and small molecule drug substances and drug products across a wide range of oral, sterile and softgel finished dosage forms. Patheon, by Thermo Fisher Scientific, has state-of-the-art development and manufacturing facilities throughout North America, Europe and Australia. We bring formulation and process development expertise to pursue early-phase goals and establish a scientifically-sound foundation for success in later stages and beyond. What’s more, we’ve created unique solutions dedicated to helping small companies at every turn on their path to market.
Many of our midsize clients are transforming the way pharmaceuticals are developed and commercialized with a new vision for their business model. Patheon CDMO services is their means to make that vision into reality. Many midsize companies can benefit from a virtual model with ready access to world-class facilities, technologies, talent and quality to build highly customized development and manufacturing solutions. This outsourced model provides the agility to quickly scale up or down in response to market conditions, enabling companies to have a lean infrastructure and to focus on their core strengths in discovery and marketing. This model keeps midsized firms from becoming mired in an overly complex supply chain of multiple specialized vendors. We can offer these companies a strategic partnership with our end-to-end capabilities taking their discovery all the way from the lab bench to the patient bedside.
Capacity. Responsiveness. Reliable quality. Those are just three of the reasons that the world’s top 20 pharmaceutical companies put their trust in our drug development and commercial manufacturing expertise. For more than 40 years, we have helped large pharma to manage the ups and downs of demand, mitigate risk with redundant resources, and take advantage of opportunities in markets around the globe. As a strategic partner to the industry’s leaders, we offer innovative solutions that preserve capital and in-house resources, freeing our clients to focus on what they do best.
As generic opportunities grow increasingly complex, we offer the technical expertise, capacity and agility to capitalize on opportunities. With state-of-the-art facilities, reliable on-time performance and industry-leading regulatory compliance, we meet strict timelines and provides a dependable, high-quality supply.